What is a lipid panel, and what does it measure?
Your lipid panel is one blood draw with several cholesterol and fat lines. Two labs can print LDL differently, and a trend needs more than one report.
Arun Verma, co-founder of Triangle · 2026-10-19
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it.
What is a lipid panel?
It's a blood test that measures cholesterol and other fats, called lipids, in your blood. NHLBI also calls it a lipoprotein panel or lipid profile. MedlinePlus lists the same idea under names such as lipid profile, lipid panel and cholesterol test. Providers use it to document baseline lipid levels and to help estimate atherosclerotic cardiovascular disease risk. CDC says the only way to know whether cholesterol is high is to get it checked with this kind of simple blood draw. The 2026 ACC/AHA Guideline on the Management of Dyslipidemia retires and replaces the 2018 cholesterol guideline and still centers the standard lipid profile in evaluation and monitoring.
What does a lipid panel measure?
The usual lines are total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol and triglycerides. Many reports also print non-HDL cholesterol, which NHLBI defines as total cholesterol minus HDL. The 2026 ACC/AHA Guideline on the Management of Dyslipidemia says a standard lipid profile directly measures total cholesterol, HDL-C and triglycerides, then estimates LDL-C, and that reporting non-HDL-C is recommended. MedlinePlus notes VLDL may appear on some panels and is not always reported. A fair question is which lines your own report prints before you compare two dates.
What is non-HDL cholesterol on the report?
It's your total cholesterol minus your HDL. NHLBI calls it a potentially useful number on a lipoprotein panel. MedlinePlus says non-HDL includes LDL and other cholesterol types such as VLDL and gives a wider view of the atherogenic cholesterol lines. The 2026 ACC/AHA dyslipidemia guideline calculates non-HDL-C the same way (total cholesterol minus HDL-C) and recommends reporting it with the standard lipid profile for risk assessment and for guiding and monitoring lipid-lowering therapy. A fair question for whoever ordered the test is whether your report includes that line and which units it uses.
Why can LDL look different from two labs?
LDL on a report is often calculated, not measured directly. MedlinePlus says the LDL line may say "calculated," meaning the lab estimated it from total cholesterol, HDL and triglycerides, or it may be measured directly from the sample. The 2026 ACC/AHA dyslipidemia guideline prefers the Martin/Hopkins or Sampson/NIH equations over the older Friedewald equation to estimate LDL-C, and prefers those equations over most direct LDL-C assays other than beta-quantification. Those newer equations matter most when triglycerides are higher or when LDL-C is low. So two labs using different methods can report different LDL numbers. You could ask which equation or method each lab used before lining two reports up.
Do you need to fast for a lipid panel?
Often no: the 2026 ACC/AHA dyslipidemia guideline recommends a standard nonfasting or fasting lipid profile, and says nonfasting samples can be used for most people because fasting and nonfasting LDL-C have similar prognostic value. A fair question for your ordering clinician is which preparation your lab expects.
How often are adults checked?
It depends on age, risk and whether a medicine changed. CDC says most healthy adults should have cholesterol checked every 4 to 6 years, and more often with a family history of high cholesterol or other listed risk factors. NHLBI's general guide is every 5 years for younger adults, every 1 to 2 years for men 45 to 65 and women 55 to 65, and yearly after 65. After lipid-lowering therapy starts or intensifies, the 2026 ACC/AHA dyslipidemia guideline supports a repeat lipid profile in 4 to 12 weeks, then every 6 to 12 months; when therapy is stable with no clinical changes, every 12 months can be appropriate. A fair question for your team is when your last panel was and when the next one is due.
How do I read a trend across panels?
A trend needs more than one result, lined up the same way. The 2026 ACC/AHA dyslipidemia guideline says response to therapy is assessed as a percentage reduction in LDL-C from baseline and as whether absolute LDL-C and non-HDL-C goals are met, and that response can vary from person to person. When panels come from different labs, you could ask whether LDL was calculated or direct, which equation was used, and whether the draw was fasting or nonfasting. You could ask which lines your clinician watches over time, and whether a change looks larger than lab-to-lab method differences.
What could I ask about my lipid panel?
You could ask which lines are on your latest report, whether non-HDL is included, whether LDL was calculated with Martin/Hopkins, Sampson/NIH or another method, and whether the draw was fasting. NHLBI notes that an Lp(a) test is not usually part of a routine lipid panel and may be ordered separately; the 2026 ACC/AHA guideline recommends measuring Lp(a) at least once in adults for risk assessment. What a given panel means for a given person is a question for the people who know your history.
Sources
- NHLBI: Blood Cholesterol - Diagnosis (last updated April 18, 2024): NHLBI says a lipoprotein panel, also called a lipid panel or lipid profile, measures the levels of LDL and HDL cholesterol and triglycerides in your blood.
- MedlinePlus: Cholesterol Levels: MedlinePlus lists other names for a cholesterol test: lipid profile and lipid panel.
- MedlinePlus: Lipid profile test: MedlinePlus Medical Encyclopedia lists alternative names including lipid profile, lipid panel, lipid test, cholesterol test and cholesterol panel (review date August 7, 2026).
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA Guideline on the Management of Dyslipidemia says a standard lipid profile assists in estimation of ASCVD risk and guidance on use and intensity of lipid-lowering therapy (Section 3.2 supportive text).
- CDC: Testing for Cholesterol (May 15, 2024): CDC says the only way to know whether you have high cholesterol is to get your cholesterol checked, and that the blood test is called a lipid profile.
- NHLBI: Blood Cholesterol - Diagnosis (last updated April 18, 2024): NHLBI says a lipoprotein panel gives total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol and triglycerides.
- CDC: Testing for Cholesterol (May 15, 2024): CDC says the cholesterol test checks LDL, HDL, triglycerides and total cholesterol.
- NHLBI: Blood Cholesterol - Diagnosis (last updated April 18, 2024): NHLBI says a lipoprotein panel may also provide non-HDL cholesterol (total cholesterol minus HDL cholesterol).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline says a standard lipid profile entails direct measurement of total cholesterol, HDL-C and triglycerides, with estimation of LDL-C, and that non-HDL-C is calculated as total cholesterol minus HDL-C (Section 3.2 synopsis).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline recommends reporting of non-HDL-C for ASCVD risk assessment and to guide initiation and monitoring of lipid-lowering therapy (Section 3.2, Recommendation 5).
- MedlinePlus: Cholesterol Levels: MedlinePlus says VLDL is not usually included in routine cholesterol tests because it is difficult to measure, and that a lab can estimate VLDL from the triglycerides level.
- MedlinePlus: Cholesterol Levels: What You Need to Know: MedlinePlus says non-HDL is total cholesterol minus HDL, includes LDL and other types such as VLDL, and gives a better picture of the "bad" types of cholesterol that can raise heart risk.
- MedlinePlus: Cholesterol Levels: MedlinePlus says the LDL listed on results may say "calculated," meaning the LDL level is an estimate based on total cholesterol, HDL and triglycerides, or LDL may be measured directly from the blood sample.
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline says that in adults and children who have undergone a standard lipid profile, use of either the Martin/Hopkins equation or the Sampson/NIH equation is preferred over calculation by the Friedewald equation to estimate LDL-C (Section 3.2, Recommendation 3).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline says use of either the Martin/Hopkins or Sampson/NIH equation is preferred over direct LDL-C measurement other than by beta-quantification to estimate LDL-C (Section 3.2, Recommendation 4).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline recommends, in adults and children, a standard nonfasting or fasting lipid profile to document baseline lipid levels, estimate ASCVD risk and guide initiation of lipid-lowering therapy (Section 3.2, Recommendation 1).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline says because fasting and nonfasting LDL-C levels have similar prognostic value, nonfasting samples can be used for most individuals (Section 3.2 synopsis).
- CDC: Testing for Cholesterol (May 15, 2024): CDC says most healthy adults should have their cholesterol checked every 4 to 6 years, and more often with a family history of high cholesterol or other listed risk factors.
- NHLBI: Blood Cholesterol - Diagnosis (last updated April 18, 2024): NHLBI's general guide says ages 20 to 65: younger adults should be screened every 5 years; men ages 45 to 65 and women ages 55 to 65 should be screened every 1 to 2 years; older than 65: every year.
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.5): The 2026 ACC/AHA dyslipidemia guideline says high-quality evidence supports monitoring response to treatment with a lipid profile 4 to 12 weeks after initiation or intensification of therapy and every 6 to 12 months thereafter (Section 3.5).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.5): The 2026 ACC/AHA dyslipidemia guideline says that for patients requiring no change in therapy, a stable response and no clinical changes, a lipid profile every 12 months is appropriate (Section 3.5).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.5): The 2026 ACC/AHA dyslipidemia guideline says response to therapy is assessed as a percentage reduction in LDL-C from baseline, as well as achievement of absolute LDL-C and non-HDL-C goals (Section 3.5).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.5): The 2026 ACC/AHA dyslipidemia guideline says response to lipid-lowering therapy can vary significantly from one patient to another (Section 3.5).
- NHLBI: Blood Cholesterol - Diagnosis (last updated April 18, 2024): NHLBI says a lipoprotein-a, or Lp(a), test is not usually part of a routine lipid panel.
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.4): The 2026 ACC/AHA dyslipidemia guideline recommends that in all adults, measurement of Lp(a) concentration is recommended at least once for ASCVD risk assessment (Section 3.4, Recommendation 1; Top Take-Home Message 6).
- 2026 ACC/AHA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (AIM): The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia retires and replaces the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (originally published March 13, 2026; Circulation. 2026;153:e1154-e1276).
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia, Circulation. 2026;153:e1154-e1276 (Section 3.2): The 2026 ACC/AHA dyslipidemia guideline says the Martin/Hopkins and Sampson/NIH equations give greater accuracy than Friedewald across a wide range of LDL-C and TG levels, particularly with TG ≥150 mg/dL, LDL-C <70 mg/dL or non-HDL-C <100 mg/dL (Section 3.2 synopsis).
Start your 7-day free trialTicker is made by Triangle. 7-day free trial, then $9 a month. Cancel anytime.